阿司匹林超敏反应:心内科医生实用指南
阿司匹林是心血管疾病抗血栓治疗的基石,但超敏反应限制其使用。本文综述阿司匹林超敏反应的流行病学、病理机制与临床表现,并给出管理策略,包括鉴别真过敏与不耐受及脱敏方案。
要点
- 阿司匹林超敏反应在普通人群患病率为0.6%-2.5%。
- 临床表现从阿司匹林加重性呼吸系统疾病到过敏性休克不等。
- 管理应避免轻易停用阿司匹林,可考虑脱敏方案。
核心结论
- 阿司匹林超敏反应是限制该救命药物使用的主要临床问题,心内科医生应避免轻易省略该药。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- 普通人群中阿司匹林超敏反应患病率为0.6%-2.5%。
- 临床表现多样,从阿司匹林加重性呼吸系统疾病到过敏性休克。
临床怎么用
- 心内科医生应鉴别真阿司匹林过敏与不耐受,并考虑脱敏方案以避免停用阿司匹林。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aspirin has been known for a long time and currently stays as a cornerstone of antithrombotic therapy in cardiovascular disease. In patients with either acute or chronic coronary syndromes undergoing percutaneous coronary intervention aspirin is mandatory in a dual antiplatelet therapy regimen for prevention of stent thrombosis and/or new ischaemic events. Aspirin is also currently a first-option antithrombotic therapy after an aortic prosthetic valve replacement and is occasionally required in addition to oral anticoagulants after implantation of a mechanical valve. Presumed or demonstrated aspirin hypersensitivity is a main clinical problem, limiting the use of a life-saving medication. In the general population, aspirin hypersensitivity has a prevalence of 0.6%-2.5% and has a plethora of clinical presentations, ranging from aspirin-exacerbated respiratory disease to anaphylaxis. Although infrequent, when encountered in clinical practice aspirin hypersensitivity poses for cardiologists a clinical dilemma, which should never be trivialized, avoiding-as much as possible-omission of the drug. We here review the epidemiology of aspirin hypersensitivity, provide an outline of pathophysiological mechanisms and clinical presentations, and review management options, starting from a characterization of true aspirin allergy-in contrast to intolerance-to suggestion of desensitization protocols.
引用
- Grimaldi S, Migliorini P, Puxeddu I, et al. Aspirin hypersensitivity: a practical guide for cardiologists. Eur Heart J. 2024. PMID: 38666370. doi:10.1093/eurheartj/ehae128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。